RE: Consolidation-vs distribution-upside comingI agree with you there.....but lets not get overly enthusiastic about him....... just so it don't go to his head.......I think the overall focus on the Biotechs the last couple of days has been on a few others like PBP , LOR , DMX , MPH etc. so this took the focus off of us and gave us an opportunity to pick up a few more at a Buck or so .......now back to the "Future Biotech Powerhouse" in the Biotech group ...Transition Therapeutics.....on our way to at least $1.50 by July and Doughly Target of $2.25 this time next year ( more than likely to be upgraded to $3.50 with a Strong Buy )